Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit® S100 for pH Responsive Release of Tenofovir.

Cazorla-Luna R, Martín-Illana A, Notario-Pérez F, Bedoya LM, Tamayo A, Ruiz-Caro R, Rubio J, Veiga MD.

Mar Drugs. 2020 Jan 9;18(1). pii: E44. doi: 10.3390/md18010044.

2.

Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV.

Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Bedoya LM, Peña J, Veiga MD.

Int J Pharm. 2019 Oct 30;570:118643. doi: 10.1016/j.ijpharm.2019.118643. Epub 2019 Aug 22.

PMID:
31446023
3.

Smart Freeze-Dried Bigels for the Prevention of the Sexual Transmission of HIV by Accelerating the Vaginal Release of Tenofovir during Intercourse.

Martín-Illana A, Notario-Pérez F, Cazorla-Luna R, Ruiz-Caro R, Veiga MD.

Pharmaceutics. 2019 May 13;11(5). pii: E232. doi: 10.3390/pharmaceutics11050232.

4.

Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV.

Cazorla-Luna R, Martín-Illana A, Notario-Pérez F, Bedoya LM, Bermejo P, Ruiz-Caro R, Veiga MD.

Polymers (Basel). 2019 Mar 13;11(3). pii: E483. doi: 10.3390/polym11030483.

5.

Tenofovir Hot-Melt Granulation using Gelucire® to Develop Sustained-Release Vaginal Systems for Weekly Protection against Sexual Transmission of HIV.

Notario-Pérez F, Cazorla-Luna R, Martín-Illana A, Ruiz-Caro R, Peña J, Veiga MD.

Pharmaceutics. 2019 Mar 20;11(3). pii: E137. doi: 10.3390/pharmaceutics11030137.

6.

Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir.

Cazorla-Luna R, Notario-Pérez F, Martín-Illana A, Ruiz-Caro R, Tamayo A, Rubio J, Veiga MD.

Pharmaceutics. 2019 Jan 5;11(1). pii: E20. doi: 10.3390/pharmaceutics11010020.

7.

Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir.

Martín-Illana A, Cazorla-Luna R, Notario-Pérez F, Bedoya LM, Ruiz-Caro R, Veiga MD.

Eur J Pharm Sci. 2019 Jan 15;127:38-51. doi: 10.1016/j.ejps.2018.10.013. Epub 2018 Oct 19.

PMID:
30343152
8.

Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.

Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Peña J, Veiga MD.

Eur J Pharm Sci. 2018 May 30;117:204-215. doi: 10.1016/j.ejps.2018.02.022. Epub 2018 Mar 21.

PMID:
29477644
9.

Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.

Notario-Pérez F, Cazorla-Luna R, Martín-Illana A, Ruiz-Caro R, Tamayo A, Rubio J, Veiga MD.

Carbohydr Polym. 2018 Jan 1;179:305-316. doi: 10.1016/j.carbpol.2017.10.001. Epub 2017 Oct 3.

PMID:
29111056
10.

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.

Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD.

Drug Des Devel Ther. 2017 Jun 15;11:1767-1787. doi: 10.2147/DDDT.S133170. eCollection 2017. Review.

11.

Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.

Notario-Pérez F, Martín-Illana A, Cazorla-Luna R, Ruiz-Caro R, Bedoya LM, Tamayo A, Rubio J, Veiga MD.

Mar Drugs. 2017 Feb 21;15(2). pii: E50. doi: 10.3390/md15020050.

12.

Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.

Sánchez-Sánchez MP, Martín-Illana A, Ruiz-Caro R, Bermejo P, Abad MJ, Carro R, Bedoya LM, Tamayo A, Rubio J, Fernández-Ferreiro A, Otero-Espinar F, Veiga MD.

Mar Drugs. 2015 Sep 18;13(9):5976-92. doi: 10.3390/md13095976.

13.

Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.

Mamani PL, Ruiz-Caro R, Veiga MD.

Int J Pharm. 2015 Oct 15;494(1):235-43. doi: 10.1016/j.ijpharm.2015.08.027. Epub 2015 Aug 11.

PMID:
26276258
14.
15.

Mucoadhesive tablets for controlled release of acyclovir.

Ruiz-Caro R, Gago-Guillan M, Otero-Espinar FJ, Veiga MD.

Chem Pharm Bull (Tokyo). 2012;60(10):1249-57. Epub 2012 Aug 2.

16.

In vitro Evaluation of Acyclovir/Chitosan Floating Systems.

Ruiz-Caro R, Veiga MD.

Materials (Basel). 2010 Dec 6;3(12):5195-5211. doi: 10.3390/ma3125195.

17.

Characterization and dissolution study of chitosan freeze-dried systems for drug controlled release.

Ruiz-Caro R, Veiga-Ochoa MD.

Molecules. 2009 Oct 30;14(11):4370-86. doi: 10.3390/molecules14114370.

Supplemental Content

Loading ...
Support Center